Home » Topics » BioWorld

BioWorld
RSS

ALZHEIMER'S MODEL COLLABORATION

March 10, 1992

PROTEIN DESIGN LABS DEAL WITH KANEBO

March 10, 1992

ANALYSTS POOH-POOH XOMA RUMORS

March 10, 1992

LIMITED APPROVAL OF ALZHEIMER'S TREATMENT

March 10, 1992

ENCOURAGING ONCOLYSIN B TRIAL RESULTS

March 10, 1992

U.S. BIOSCIENCE, FDA HOLD ETHYOL MEETING

March 10, 1992

UNIVAX TESTING NOVA'S LIPOSPHERES

March 10, 1992

IND FOR BLOOD CLOT IMAGING AGENT

March 10, 1992

CREATIVE BIOMOLECULES TO GO PUBLIC

March 10, 1992

APPOINTMENTS AND ADVANCEMENTS

March 9, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...